These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Psychoendocrine study of oral contraceptive agents. Kane FJ; Lipton MA; Krall AR; Obrist PA Am J Psychiatry; 1970 Oct; 127(4):443-50. PubMed ID: 4394090 [No Abstract] [Full Text] [Related]
24. Plasma renin activity, renin substrate and aldosterone during treatment with various oral contraceptives. Katz FH; Beck P J Clin Endocrinol Metab; 1974 Dec; 39(6):1001-4. PubMed ID: 4139170 [No Abstract] [Full Text] [Related]
25. Plasma ascorbic acid concentrations and oral contraceptives. Rivers JM; Devine MM Am J Clin Nutr; 1972 Jul; 25(7):684-9. PubMed ID: 5035056 [No Abstract] [Full Text] [Related]
26. The effect of an oral contraceptive on urinary gonadotrophin in women at mid-cycle. Brown PS; Wells M; Warnock DG J Reprod Fertil; 1966 Jun; 11(3):481-3. PubMed ID: 5940546 [No Abstract] [Full Text] [Related]
28. Longitudinal study of the effects of oral contraceptives on human chromosomes. de Gutiérrez AC; Lisker R Ann Genet; 1973 Dec; 16(4):259-62. PubMed ID: 4544089 [No Abstract] [Full Text] [Related]
29. Plasma lipid and lipoprotein alterations during oral contraceptive administration. Sachs BA; Wolfman L; Herzig N Obstet Gynecol; 1969 Oct; 34(4):530-5. PubMed ID: 5822679 [No Abstract] [Full Text] [Related]
30. [Investigations on the influence of ovulation inhibitors on the development and prognosis of chronic hepatopathies]. Sensing H Dtsch Gesundheitsw; 1974 Mar; 29(9):405-7. PubMed ID: 4142435 [No Abstract] [Full Text] [Related]
31. The effects of oral contraceptives on glucose tolerance. Boshell BR; Roddam RF; McAdams GL; Fox OJ J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:77-88. PubMed ID: 5288232 [No Abstract] [Full Text] [Related]
32. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy]. Zellner P; Klinger G Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274 [No Abstract] [Full Text] [Related]
33. [Behavior of serum copper and iron under the influence of the ovulation inhibitor Ovosiston]. Methfessel HD; Mlytz H; Methfessel G; Löffler F Z Gesamte Inn Med; 1969 Oct; 24(19):659-61. PubMed ID: 4188438 [No Abstract] [Full Text] [Related]
34. [Investigations of the cervical factor in the treatment with Ovulen]. Odeblad E Lakartidningen; 1967 Jul; 64(29):2903-6. PubMed ID: 5597595 [No Abstract] [Full Text] [Related]
35. [Oral contraceptives and cell division]. Sebaoun M; Fournier M; Netter A Sem Hop; 1968 Nov; 44(46):2817-8. PubMed ID: 4311292 [No Abstract] [Full Text] [Related]
36. [Radioimmunological study of the effect of hormonal contraceptives upon the progesterone level of saliva (author's transl)]. Arnold M; Tóth I; Faredin I Zahn Mund Kieferheilkd Zentralbl; 1980; 68(7):713-8. PubMed ID: 6163264 [No Abstract] [Full Text] [Related]
37. Growth hormone alterations by a sequential-type oral contraceptive. Spellacy WN; Buhi WC; Bendel RP Obstet Gynecol; 1969 Apr; 33(4):506-10. PubMed ID: 4180423 [No Abstract] [Full Text] [Related]
38. [Ovulation inhibitors and the sexual behavior of women]. Aresin L Z Gesamte Hyg; 1970 Apr; 16(4):291-2. PubMed ID: 4108398 [No Abstract] [Full Text] [Related]
39. Sequential approach to oral contraceptive therapy. Balin H; Wan LS; Rajan R Int J Fertil; 1969; 14(4):300-8. PubMed ID: 4186408 [No Abstract] [Full Text] [Related]
40. [Urinary level of metabolites of steroid hormones in women receiving Gestranol]. Giermańska T; Jablońska K; Filc-Bauer A Pol Tyg Lek; 1972 Nov; 27(48):1879-81. PubMed ID: 4118934 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]